Upgrade to SI Premium - Free Trial

Neurocrine Bio. (NBIX) PT Lowered to $105 at Cowen

February 6, 2019 7:54 AM
Cowen analyst Phil Nadeau lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $105.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles